Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sanofi SA (SNY) vs Veritone Inc (VERI) Price & Performance

Sanofi SATrade
Veritone IncTrade

Price performance (Past 24H)

Key statistics

Sanofi SA vs Veritone Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Sanofi SA is far larger — about 1074.1× Veritone Inc's market cap, and Sanofi SA pays a 5.5% dividend while Veritone Inc pays none. Which is the better fit depends on your goals.

SNYVERI
Market Cap
$104.83B$97.60M
Sector
HealthTechnology
52-Week High
$52.34$8.39
52-Week Low
$41.33$1.02
Enterprise Value
$121.32B$129.63M
Dividend Yield
5.5%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY

About Veritone Inc

Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.

Read more on VERI